CD8A and neoplasm: For example, higher levels of CD3 + and CD8 + tumour-infiltrating lymphocytes are associated with a favourable response to NACRT in rectal cancer [9], whilst regulatory T cells suppress anti-tumour immunity and are associated with poor response to NACRT [10].